LPC
ISEE

Lion Point Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Lion Point Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,541
Closed -$284K – 41
2022
Q3 		$284K Sell
29,541
-676,627
-96% -$8.88M 0.06% 38
2022
Q2 		$6.61M Hold
706,168
– – 0.75% 21
2022
Q1 		$11.9M Hold
706,168
– – 2.76% 12
2021
Q4 		$11.8M Hold
706,168
– – 3.17% 15
2021
Q3 		$11.5M Buy
+706,168
New +$7.69M 2.15% 13

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lion Point Capital's ISEE Position: Q4 2022 in Review

Lion Point Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 29,541 shares — an estimated $284K sold.

Lion Point Capital first reported a position in ISEE in Q3 2021 and held it in 5 quarters. The position peaked at $11.9M in Q1 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Lion Point Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Lion Point Capital sold 29,541 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $284K.
  • Lion Point Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Lion Point Capital's IVERIC bio, Inc. Common Stock position peaked at $11.9M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Lion Point Capital's 13F filing for Q4 2022, filed 14 Feb 2023.